1214 Research Boulevard
Suite 1011 A
About Sidero BioscienceSidero Biosciences, LLC (Sidero) is a clinical stage biotechnology company advancing disruptive technologies targeting human digestive health. The Siderosorb™ Medical Food platform delivers beneficial proteins/complexes directly to the gastrointestinal (GI) tract to ameliorate human disease.
Medical Foods are not subject to the onerous time and cost of drug development. We are poised to rapidly advance to a market launch.?
CEO: Darren Wolfe
CFO: Michael Armstrong
COO: Robert E. Harbaugh
2 articles with Sidero Bioscience
Sidero Bioscience Announces Agreement with SRS Life Sciences for Commercialization of BioFe for Iron Deficiency
Sidero Bioscience, LLC, a clinical stage biotechnology company targeting human digestive health, announces the execution of a term sheet agreement with SRS Life Sciences PTE. LTD, a leading life sciences company.
Sidero Bioscience Release: Biotech Awarded Grant To Support Clinical Trial Of BioFe Medical Food For The Management Of Iron Deficiency